Geissler, K., Jäger, E., Barna, A., Sliwa, T., Knöbl, P., Schwarzinger, I., Gisslinger, H. and Valent, P. (2016) “Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?”, Haematologica. Pavia, Italy, 101(12), pp. e492-e492. doi: 10.3324/haematol.2016.156448.